05:54 PM EDT, 06/16/2025 (MT Newswires) -- Yann Echelard, Director, on June 12, 2025, sold 10,000 shares in Tg Therapeutics ( TGTX ) for $369,400. Following the Form 4 filing with the SEC, Echelard has control over a total of 228,816 common shares of the company, with 228,816 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1001316/000143774925020546/xslF345X05/rdgdoc.xml